153 related articles for article (PubMed ID: 22971963)
21. [The immunohistochemical heterogeneity of mesangioproliferative glomerulonephritis].
Varshavskiĭ VA; Gasanov AB
Arkh Patol; 1990; 52(8):33-7. PubMed ID: 1704206
[TBL] [Abstract][Full Text] [Related]
22. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
23. Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis.
Takei T; Itabashi M; Moriyama T; Shimizu A; Tsuruta Y; Ochi A; Nakayama K; Iwasaki C; Uchida K; Nitta K
Clin Exp Nephrol; 2013 Feb; 17(1):92-8. PubMed ID: 22821391
[TBL] [Abstract][Full Text] [Related]
24. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
[TBL] [Abstract][Full Text] [Related]
25. [Ultrastructural study on membranoproliferative glomerulonephritis with special reference to subepithelial deposits].
Sato H
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):973-83. PubMed ID: 2263028
[TBL] [Abstract][Full Text] [Related]
26. Treatment of membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Niigata Research Group of Glomerulonephritis and Nephrotic Syndrome.
Nishi S; Ueno M; Shimada H; Oosawa Y; Iino N; Iguchi S; Karasawa R; In H; Kawashima S; Saito N; Imai N; Saito K; Suzuki S; Arakawa M; Gejyo F
Intern Med; 2000 Oct; 39(10):788-93. PubMed ID: 11030201
[TBL] [Abstract][Full Text] [Related]
27. The predominance of membranoproliferative glomerulonephritis in childhood nephrotic syndrome in Ibadan, Nigeria.
Asinobi AO; Gbadegesin RA; Adeyemo AA; Akang EE; Arowolo FA; Abiola OA; Osinusi K
West Afr J Med; 1999; 18(3):203-6. PubMed ID: 10593158
[TBL] [Abstract][Full Text] [Related]
28. Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative glomerulonephritis.
Kawasaki Y; Kanno S; Ono A; Suzuki Y; Ohara S; Sato M; Suyama K; Hashimoto K; Hosoya M
Pediatr Nephrol; 2016 Jul; 31(7):1091-9. PubMed ID: 26846787
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features of membranoproliferative glomerulonephritis under a new classification.
Nargund P; Kambham N; Mehta K; Lafayette RA
Clin Nephrol; 2015 Dec; 84(6):323-30. PubMed ID: 26445002
[TBL] [Abstract][Full Text] [Related]
30. Pathology of idiopathic nephrotic syndrome in children: are the adolescents different from young children?
Mubarak M; Kazi JI; Lanewala A; Hashmi S; Akhter F
Nephrol Dial Transplant; 2012 Feb; 27(2):722-6. PubMed ID: 21551090
[TBL] [Abstract][Full Text] [Related]
31. Primary membranoproliferative glomerulonephritis in Sfax, Tunisia: epidemiologic profile and prognostic factors.
Agrebi I; Kammoun K; Dammak N; Hachicha J; Boudawara T; Jarraya F; Hmida MB
Pan Afr Med J; 2021; 38():218. PubMed ID: 34046124
[TBL] [Abstract][Full Text] [Related]
32. Pattern of glomerular diseases in Sudanese children: a clinico-pathological study.
Abdelraheem MB; Ali el-TM; Mohamed RM; Hassan EG; Abdalla OA; Mekki SO; Yousif BM; Watson AR
Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):778-83. PubMed ID: 20587895
[TBL] [Abstract][Full Text] [Related]
33. Hypocomplementemia and membranoproliferative glomeruloneophritis in children.
Iitaka K; Nakamura S; Moriya S; Koshino H; Iwanami N; Sakai T; Motoyama O
Clin Exp Nephrol; 2005 Mar; 9(1):31-3. PubMed ID: 15830270
[TBL] [Abstract][Full Text] [Related]
34. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk.
Little MA; Dupont P; Campbell E; Dorman A; Walshe JJ
Kidney Int; 2006 Feb; 69(3):504-11. PubMed ID: 16395262
[TBL] [Abstract][Full Text] [Related]
35. Re-evaluation of the classification system for membranoproliferative glomerulonephritis.
Lu Y; Shen P; Li X; Xu Y; Pan X; Wang W; Chen X; Zhang W; Ren H; Chen N
Contrib Nephrol; 2013; 181():175-84. PubMed ID: 23689579
[TBL] [Abstract][Full Text] [Related]
36. Membranoproliferative glomerulonephritis in Russian population.
Dobronravov VA; Smirnov AV
Ter Arkh; 2018 Dec; 90(12):39-47. PubMed ID: 30701832
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and pathological features of type I and III membranoproliferative glomerulonephritis].
Chen HP; Li LS; Bai XY
Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):293-6, 318. PubMed ID: 1478129
[TBL] [Abstract][Full Text] [Related]
38. Histopathological spectrum of childhood nephrotic syndrome in Indian children.
Kumar J; Gulati S; Sharma AP; Sharma RK; Gupta RK
Pediatr Nephrol; 2003 Jul; 18(7):657-60. PubMed ID: 12743793
[TBL] [Abstract][Full Text] [Related]
39. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
[TBL] [Abstract][Full Text] [Related]
40. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis.
Gupta N; Wakefield DN; Clapp WL; Garin EH
Nefrologia; 2017; 37(1):78-86. PubMed ID: 27595516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
